Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells
Purpose: Targeted treatment of breast cancer through combination of chemotherapeutic agents and siRNA had been drawing much attention in recent researches. This study was carried out to evaluate mucin1 aptamer-conjugated chitosan nanoparticles containing docetaxel and cMET siRNA on SKBR3 cells. Meth...
Main Authors: | Naime Majidi Zolbanin, Reza Jafari, Jafar Majidi, Fatemeh Atyabi, Mehdi Yousefi, Farhad Jadidi-Niaragh, Leili Aghebati-Maleki, Dariush Shanehbandi, Mohammad-Sadegh Soltani Zangbar, Alireza Mohajjel Nayebi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2018-08-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | http://apb.tbzmed.ac.ir/PDF/apb-8-383.pdf |
Similar Items
-
cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance
by: Nele Van Der Steen, et al.
Published: (2015-03-01) -
The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker
by: Daniel Martin Klotz, et al.
Published: (2021-09-01) -
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma
by: Masahiro Ohara, et al.
Published: (2021-03-01) -
TR1801‐ADC: a highly potent cMet antibody–drug conjugate with high activity in patient‐derived xenograft models of solid tumors
by: Marco Gymnopoulos, et al.
Published: (2020-01-01) -
Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer
by: Ghassami E, et al.
Published: (2018-01-01)